ClearPoint Maestro CPM-SFW-1
ClearPoint Maestro CPM-SFW-1 is an image segmentation application software (FDA Class II; FDA product code QIH, Automated Radiological Image Processing Software) made by Clearpoint Neuro, Inc., listed in FDA GUDID since 4 Oct 2022 (UDI-DI 00850359007966), registry data as of 22 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00850359007966 | Date4 Oct 2022 | StatusListed |
Official records
- AccessGUDID record 00850359007966
From the FDA record
- Device description
- ClearPoint Maestro Brain Model Software Version 1.0
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- ClearPoint Maestro
- Generic name
- Image segmentation application software
- Model / Ref / Catalog
- CPM-SFW-1
- Primary DI / UDI-DI
- 00850359007966
- FDA product code
- QIH
- GMDN term
- Image segmentation application software
- Device class
- Class II
- Regulation number
- 892.2050
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code QIH (Automated Radiological Image Processing Software).
- Cleerly LABS (v2.0) by CLEERLY, INC
- OptimMRI by Rebrain, Sas
- Sonix Health by Ontact Health Co., Ltd.
- Viz HDS, Viz Volume Plus, Viz ICH+ by Viz.ai
- Artificial Intelligence Renal Assessment (AIRA) Version 1 by Aramis Global AI Consultancies, LLC
- uOmnispace.CT Medical Image Post-processing Software by Shanghai United Imaging Healthcare Co., Ltd.
- Alzevita by TOPIA MEDTECH LIMITED
- SIS System by Surgical Information Sciences, Inc.
- Myomics by Phantomics, Inc.
- LungMaps by Siemens Healthineers AG